Sanofi (SNY) Free Cash Flow (2009 - 2026)

Sanofi has disclosed Free Cash Flow across 10 years of filings, most recently posting $2.9 billion for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $2.9 billion, up 24.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.2 billion (up 18.68% YoY), and the FY2025 annual result was $8.4 billion, up 33.47% from the prior year.
• Free Cash Flow came in at $2.9 billion for Q1 2026 at Sanofi, down from $11.2 billion in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $12.0 billion in Q4 2023 to a low of -$495.4 million in Q2 2024.
• The 5-year median for Free Cash Flow is $3.1 billion (2022), against an average of $5.2 billion.
• Across the five-year window, Free Cash Flow slumped 155.68% in 2024 and jumped 413.97% in 2025, its largest moves.
• Sanofi's Free Cash Flow stood at $11.2 billion in 2022, then climbed by 6.9% to $12.0 billion in 2023, then dropped by 12.22% to $10.5 billion in 2024, then rose by 6.97% to $11.2 billion in 2025, then sank by 74.49% to $2.9 billion in 2026.
• The last three Free Cash Flow figures came in at $2.9 billion (Q1 2026), $11.2 billion (Q4 2025), and $8.5 billion (Q3 2025), per Business Quant data.